|
|
Norman
G. Anderson
Biography
Norman G. Anderson, Ph.D. is Senior Scientific Advisor to the
Plasma Proteome Institute, Washington DC (www.plasmaproteome.org).
The Institute aims to foster a comprehensive exploration of the
proteins of human blood plasma (the plasma proteome) and the rapid
application of novel protein measurements in clinical diagnostics.
Prior to joining PPI, Dr. Anderson was Chief Scientist of the
Proteomics Division at Large Scale Biology Corporation (Nasdaq:
LSBC), whose proteomics division he co-founded in 1985 (as Large
Scale Biology) prior to its merger in 1999 with Biosource Technologies.
Dr. Anderson's current primary interests are in virus isolation
and rapid analysis, precision protein fractionation and in further
advancing automated proteomic analysis.
Dr.
Anderson obtained his B.A. in Zoology (1947), an M.A. in Physiology
(1948), and a Ph.D. in Biochemistry (1951) from Duke University.
During his eventful career, Dr. Anderson has served as Director
of the Molecular Anatomy Program of the US Department of Energy,
first at the Oak Ridge National Laboratory and later at the Argonne
National Laboratory. During his time at Oak Ridge, he invented
the first high-pressure liquid chromatography systems, the zonal
ultracentrifuge (used for the discovery and, later, industrial
production of viruses for vaccines, including hepatitis) and the
centrifugal fast analyzer (which revolutionized clinical chemistry
in the 1970's). At Argonne, he pioneered (with Leigh Anderson)
the development of two-dimensional electrophoresis into a high-throughput
research tool for proteomics.
Dr.
Anderson holds 31 patents and has written over 300 scientific
publications in cell physiology, cell fractionation, radiation
biology, ultracentrifuge development, vaccine purification,
development of immunological techniques, development of centrifugal
fast clinical analyzers, rapid recycling affinity chromatography,
the theory of perfect sets, evolutionary significance of viral
transmission of host genes, high resolution two-dimensional electrophoresis,
electrophoretic protein mapping and database production and
management, large-scale cloning and dot-blot hybridization, multiple-parallel
peptide synthesis, large scale synthesis of antisense oligonucleotides,
and development of rapid methods for detecting and diagnosing
viral infections in man. He has received 17 Small Business Innovation
Research (SBIR) grants.
Invited
lectures include the Pasteur Institute's 100 Anniversary Commemoration
of the Death of Louis Pasteur; the Arne Tiselius Lectureship,
Sandefjord, Norway, June 1989. Awards include receipt of the Distinguished
Clinical Chemist Award from the International Federation for Clinical
Chemistry in San Francisco, July 22, 1990; the Tennessee Technology
Foundation Outstanding Scientist Award, 1986; the Career Patent
Leader Award, 1984, Argonne National Laboratory; the 1983 Pittsburgh
Analytical Chemistry Award for work in high resolution two-dimensional
electrophoresis (shared with N. Leigh Anderson); an Docteur Honoris
Causa, University of Nancy, France; the John Scott Medal and Award
for the invention of the zonal ultracentrifuge, December, 1972
(previous winners include M Curie, Fleming, Land, and Wright);
the Atomic Energy Commission Citation and Gold Medal for the invention
and development of the K-II vaccine-purification ultracentrifuge
and for contributions to the development of a purified influenza
vaccine presented by Secretary James Schlessinger, December, 1972;
the Preis für Biochemische Analytik, awarded by the Deutsche
Gesellschaft für Klinische Chemie for the invention and development
of the centrifugal fast analyzer as the most outstanding analytical
development in clinical chemistry worldwide during a two-year
period, 1972; a U.S. Navy Special Citation, 1946, given by Edward
Steichen for outstanding work as a combat photographic officer
in the submarine service in the Pacific during WWII.
Bibliography
|
